SKAN Group AG
SIX:SKAN
Intrinsic Value
SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. [ Read More ]
The intrinsic value of one SKAN stock under the Base Case scenario is 87.71 CHF. Compared to the current market price of 85.1 CHF, SKAN Group AG is Undervalued by 3%.
Valuation Backtest
SKAN Group AG
Run backtest to discover the historical profit from buying and selling SKAN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of SKAN Group AG's business.
What risks and challenges
does SKAN Group AG face in the near future?
Summarize the latest earnings report
of SKAN Group AG.
Provide P/E
for SKAN Group AG and its competitors.
Balance Sheet Decomposition
SKAN Group AG
Current Assets | 298.7m |
Cash & Short-Term Investments | 97.9m |
Receivables | 45.4m |
Other Current Assets | 155.4m |
Non-Current Assets | 98.6m |
Long-Term Investments | 3.4m |
PP&E | 91.3m |
Intangibles | 3m |
Other Non-Current Assets | 861k |
Current Liabilities | 218.7m |
Accounts Payable | 28.7m |
Other Current Liabilities | 190m |
Non-Current Liabilities | 23.3m |
Long-Term Debt | 6.3m |
Other Non-Current Liabilities | 17m |
Earnings Waterfall
SKAN Group AG
Revenue
|
295.8m
CHF
|
Cost of Revenue
|
-73.3m
CHF
|
Gross Profit
|
222.5m
CHF
|
Operating Expenses
|
-186.5m
CHF
|
Operating Income
|
36m
CHF
|
Other Expenses
|
-8.6m
CHF
|
Net Income
|
27.3m
CHF
|
Free Cash Flow Analysis
SKAN Group AG
What is Free Cash Flow?
SKAN Profitability Score
Profitability Due Diligence
SKAN Group AG's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
SKAN Group AG's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
SKAN Solvency Score
Solvency Due Diligence
SKAN Group AG's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
SKAN Group AG's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SKAN Price Targets Summary
SKAN Group AG
According to Wall Street analysts, the average 1-year price target for SKAN is 93.16 CHF with a low forecast of 74.74 CHF and a high forecast of 113.4 CHF.
Shareholder Return
SKAN Price
SKAN Group AG
Average Annual Return | -4.58% |
Standard Deviation of Annual Returns | 24.86% |
Max Drawdown | -47% |
Market Capitalization | 1.9B CHF |
Shares Outstanding | 22 483 500 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Officers
The intrinsic value of one SKAN stock under the Base Case scenario is 87.71 CHF.
Compared to the current market price of 85.1 CHF, SKAN Group AG is Undervalued by 3%.